AELIX Therapeutics

On #WorldAIDSday, @AELIX_Th acknowledges the progress towards a cure for HIV infection. This is not possible without the continued engagement of study participants, funders, and the research teams. The goal remains, the journey continues, and we thank you for your participation

@AELIX_Th is attending the Jeffries Healthcare Conference in London on 14-16 Nov. Thomas Hecht, our Executive Chairman and Karen Wagner, YsiosCapital and Aelix BoD member, will be happy to meet you and discuss our latest research progress in development of #vaccines for #HIV cure

Christian Brander and Thomas Hecht from the @AELIX_Th team are attending the upcoming World Vaccine Conference #WVCEU in #Barcelona. We will be happy to meet you there and to discuss our latest research progress and #clinical data on development of #vaccines for #HIV cure.

AELIX is proud to be shortlisted by @LaBiotech as one of the five #Spanish #biotech #companies one should know about: Five biotech companies you should know about in Spain (buff.ly/2UE17Hk)

AELIX is proud to support the #LGTBIQ+ community and work towards a better world without prejudice. #pride #lgtbiq <a href="buff.ly/3PvXSAB">Image by Vectonauta</a> on Freepik

AELIX Therapeutics keeps supporting @FundlaCaixa’s project Alliance for Child Vaccination to contribute to the fight to reduce premature deaths of children in the world’s most vulnerable areas and to give them hope for a better future. #VacunaciónlaCaixa @FundlaCaixa

Jordi Naval and Christian Brander explain the @AELIX_Th ’ HIV #therapeutic #vaccine and the results of the @AELIX_Th #clinical #trials in the interview for @CincoDiascom ⬇️ Click⬇️ buff.ly/40TtgM9

Small team running a big project! We are proud to be a part of the @AELIX_Th success story that we hope will pave a path for an effective #therapeutic #vaccine against #HIV #infection.

Christian Brander explains the @AELIX_Th #HIV #therapeutic #vaccine in the recent interview for @elEconomistaes ➡️ ow.ly/EifW50N9wpp

AELIX has presented promising top-line results from the #clinical #study AELIX-003 at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI). #HIV #Innovation #Immunotherapy #therapeuticvaccine ➡️ ow.ly/LnJ550MYssf

We are excited to announce that the lead investigator, @BeaMothe and our CSO, Christian Brander, will present the topline results from our clinical trial AELIX-003 at the CROI conference. The data will be presented in a late-breaker session on Feb 21st. ow.ly/lIyx50MSUmq

#article @IrsiCaixa and @AELIX_Th explain in @Biotech_Spain article what is needed to develop a #therapeutic #HIV #vaccine ow.ly/z4yT50MJ798

On #WorldAIDSday, @AELIX_Th wishes to thank all our #research teams, #funders and study participants, for their invaluable contribution in our quest of finding a functional cure for #HIV infection to help achieve physical, mental and social wellbeing of all people living with HIV

Exclusive #VaccineNation interview with @AELIX_Th’s CSO, Dr. Christian Brander, on the development of #HIV #therapies. ow.ly/Jk8Y50LH2QI

Positive results from @AELIX_Th' #HIV #therapeutic #vaccine #clinicalstudy AELIX-002 have been published in @NatureMedicine: ow.ly/kEak50Lrau6”

Meet us at World Vaccine Conference #WVCEU where @AELIX_Th will be presenting this year. Excited to be participating together with other world class vaccine researchers and to provide an update on AELIX´s cutting edge research on the development of vaccines for #HIV cure.

AELIX Therapeutics has made a donation to @FundlaCaixa ’s project Alliance for Child Vaccination to contribute to the fight to reduce premature deaths of children in the world’s most vulnerable areas and to give them hope for a better future. #VacunaciónlaCaixa @FundlaCaixa

We congratulate FLS on their 30th anniversary and thank them for their invaluable assistance in helping AELIX Therapeutics to advance the HIV cure research agenda through the excellent clinical trials support provided by FLS for our #HTI vaccine studies. ow.ly/1XWC50JaZps